Home/Filings/4/0001628280-21-023469
4//SEC Filing

Ibrahim Ramy 4

Accession 0001628280-21-023469

CIK 0001860782other

Filed

Nov 15, 7:00 PM ET

Accepted

Nov 16, 6:41 AM ET

Size

13.9 KB

Accession

0001628280-21-023469

Insider Transaction Report

Form 4
Period: 2021-11-11
Ibrahim Ramy
Director
Transactions
  • Award

    Common Stock

    2021-11-11+2,0023,450 total
  • Award

    Common Stock

    2021-11-11+1,4481,448 total
  • Award

    Stock Option (right to buy)

    2021-11-11+3,2193,219 total
    Exercise: $50.98Exp: 2031-06-15Common Stock (3,219 underlying)
  • Award

    Stock Option (right to buy)

    2021-11-11+2,8972,897 total
    Exercise: $75.10Exp: 2031-01-07Common Stock (2,897 underlying)
Footnotes (8)
  • [F1]In connection with the separation (the "Separation") of seventy bio, Inc. ("2seventy") from bluebird bio, Inc. ("bluebird"), the reporting person received restricted stock units, each representing the right to receive a share of 2seventy's common stock, as a result of the adjustment of existing bluebird restricted stock units prior to the Separation (see footnotes 2 and 3). This restricted stock unit award vests ratably over three years in annual installments commencing on January 7, 2021.
  • [F2]bluebird equity awards granted prior to January 1, 2021 were converted into equity awards of both bluebird and 2seventy. The number of shares underlying the converted bluebird equity awards was determined by multiplying the number of shares underlying the existing bluebird equity award by a fraction, the numerator of which is the volume-weighted average trading price of bluebird common stock (trading "regular way") on the five trading days immediately prior to the distribution date (the "bluebird Pre-Distribution VWAP"), the denominator of which is the sum of (1) the volume-weighted average trading price of 2seventy common stock (trading "regular way") on the five trading days immediately following the distribution date (the "2seventy VWAP") multiplied by the distribution ratio and (2) the volume-weighted average trading price of bluebird common stock (trading "regular way") on the five trading days immediately following the distribution date (the "bluebird Post-Distribution VWAP").
  • [F3]The number of shares underlying the converted 2seventy equity awards was determined by multiplying the number of shares underlying the existing bluebird equity awards by a fraction, the numerator of which is the bluebird Pre-Distribution VWAP and the denominator of which is the sum of (1) the 2seventy VWAP multiplied by the distribution ratio and (2) the quotient obtained by dividing the bluebird Post-Distribution VWAP by the distribution ratio. bluebird equity awards granted on or after January 1, 2021, such equity awards were converted into 2seventy equity awards. The number of shares of 2seventy common stock underlying such converted equity awards is equal to the number of shares of bluebird common stock subject to the equity award immediately prior to the distribution multiplied by a fraction, the numerator of which is the bluebird Pre-Distribution VWAP and the denominator of which is the 2seventy VWAP.
  • [F4]In connection with the Separation, the reporting person received a grant of restricted stock units, each representing the right to receive a share of 2seventy's common stock, as a result of the adjustment of existing bluebird restricted stock units prior to the Separation (see footnotes 2 and 3). This restricted stock unit award vests 100% on the earlier of June 15, 2022 or the date of the next annual meeting of stockholders.
  • [F5]Includes [_] shares of 2seventy's common stock received in a pro rata distribution by bluebird as a result of the Separation.
  • [F6]Represents options to purchase shares of 2seventy's common stock granted to the reporting person in connection with the Separation (see footnotes 2 and 3).
  • [F7]This option vests ratably over three years in annual installments commencing on January 7, 2021 (see footnotes 2 and 3).
  • [F8]This option vests 100% on the earlier of June 15, 2022 or the date of the next annual meeting of stockholders (see footnotes 2 and 3).

Issuer

2seventy bio, Inc.

CIK 0001860782

Entity typeother

Related Parties

1
  • filerCIK 0001787662

Filing Metadata

Form type
4
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 6:41 AM ET
Size
13.9 KB